Document is current
Any future updates will be listed below
-
Authors
Krishnamurthy, Nithya
Orloff, Jeremy
Piontkowski, Austin J.
Powers, Camille M.
Ungar, Benjamin
Gulati, Nicholas
- License Information
-
More Information
Article History
Received: 29 January 2025
Revised: 8 March 2025
Accepted: 21 March 2025
First Online: 11 April 2025
Declarations
:
: Reviewed and deemed exempt by Icahn School of Medicine at Mount Sinai institutional review board; study #: STUDY-22-00884
: Not applicable.
: BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Incyte, Rapt Therapeutics, and Pfizer. He is also a consultant for Arcutis Biotherapeutics, Bristol Myers Squibb, Castle Biosciences, Fresenius Kabi, Galderma, Janssen, Lilly, Pfizer, Primus Pharmaceuticals, Sanofi, and UCB. The other authors have no conflicts of interest.
